Form 8-K Checkpoint Therapeutics, For: Jul 15

Exhibit 16.1

July 21, 2022

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on July 15, 2022, to be filed by our former client, Checkpoint Therapeutics, Inc. We agree with the statements made in response to that Item insofar as they relate to our Firm.

Very truly yours,

BDO USA, LLP, a Delaware limited liability partnership, is the U.S. member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms.

BDO is the brand name for the BDO network and for each of the BDO Member Firms.

You May Also Be Interested In

• Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ventyx, Anavex, and Checkpoint and Encourages Investors to Contact the Firm
• Track and Trace Solutions Market Size to be Worth USD 17.15 Billion by 2031, with Notable CAGR of 19.27%
• FIFTH WALL NAMES JEREMY FOX & G.M. NICHOLAS VIK CO-PRESIDENTS